Usage haloperidol for delirium in cancer patients

被引：32

作者：

Akechi, T

Uchitomi, Y

Okamura, H

Fukue, M

Kagaya, A

Nishida, A

Oomori, N

Yamawaki, S

机构：

[1] NATL CANC CTR,RES INST E,PSYCHOONCOL DIV,KASHIWA,CHIBA 277,JAPAN

[2] NATL CANC CTR,DEPT PSYCHIAT,CHUO KU,TOKYO 104,JAPAN

[3] HIROSHIMA UNIV,SCH MED,DEPT PSYCHIAT & NEUROSCI,MIMAMI KU,HIROSHIMA 734,JAPAN

来源：

SUPPORTIVE CARE IN CANCER | 1996年 / 4卷 / 05期

关键词：

cancer patients; delirium; haloperidol;

D O I：

10.1007/BF01788847

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Although haloperidol is mainly used for the medical treatment of delirium in cancer patients, there are no universally accepted guidelines for its usage. We accordingly assessed the usefulness in managing delirium of a haloperidol treatment regimen in ten delirious cancer patients. The results of this preliminary study suggest that, in the management of delirium, appropriate usage of haloperidol on the first day is important as it affects the dosage thereafter.

引用

页码：390 / 392

页数：3

共 10 条

[1] Adams F, 1986, Psychosomatics, V27, P33
[2] FLEISHMAN S, 1989, HDB PSYCHOONCOLOGY, P342
[3] Lipowski Z., 1990, Delirium: Acute confusional states
[4] MASSIE MJ, 1983, AM J PSYCHIAT, V140, P1048
[5] Moulaert P, 1989, Acta Anaesthesiol Belg, V40, P183
[6] PSYCHOTROPIC MEDICATIONS IN PATIENTS WITH CANCER
PETERSON, LG
LEIPMAN, M
BONGAR, B
[J]. GENERAL HOSPITAL PSYCHIATRY, 1987, 9 (05) : 313 - 323
[7] ACUTE CONFUSIONAL STATES IN PATIENTS WITH ADVANCED CANCER
STIEFEL, F
FAINSINGER, R
BRUERA, E
[J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (02) : 94 - 98
[8] A SYMPTOM RATING-SCALE FOR DELIRIUM
TRZEPACZ, PT
BAKER, RW
GREENHOUSE, J
[J]. PSYCHIATRY RESEARCH, 1988, 23 (01) : 89 - 97
[9] WEINRICH S, 1994, CANCER-AM CANCER SOC, V74, P2079, DOI 10.1002/1097-0142(19941001)74:7+<2079::AID-CNCR2820741716>3.0.CO
[10] 2-0

← 1 →